
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
inVentiv Health and Medidata announced a multi-year partnership to bring patient-centric technology to the biopharma indstry. inVentiv selected Medidata Enroll-Medidata's electronic informed consent (eConsent) technology-to vary the use of patient-centered technology to help benefit patients, sites, and the biopharma industry.
Read the full release






